tm logo
ZAGBEMIZ
Live/Pending
PUBLISHED FOR OPPOSITION

on 17 Sep 2024

Last Applicant/ Owned by

YUQI STREET, HUISHAN DISTRICT,

WUXI CITY

CN

214000

Serial Number

98339914 filed on 03rd Jan 2024

Registration Number

N/A

Correspondent Address

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC

Suite 2100

Chicago, IL 60606

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ZAGBEMIZ

Medicines for human purposes, namely, medicines for the treatment of cancer, cardiovascular diseases, hematologic diseases, neurological diseases, gastrointestinal and genetic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, coagulation disorders, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metab Read More

Classification Information


Class [005]
Pharmaceutical Products


Medicines for human purposes, namely, medicines for the treatment of cancer, cardiovascular diseases, hematologic diseases, neurological diseases, gastrointestinal and genetic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, coagulation disorders, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental, behavioral and neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin, congenital bleeding disorders and acquired bleeding disorders, disorders due to a deficiency of a coagulation factor, disorders due to the presence of acquired inhibitors to a coagulation factor, hematologic disorders, hemorrhagic disorders, Von Willebrands' disease, disorders resulting from anticoagulant therapy with a vitamin-K antagonist, hereditary platelet disorders, vitamin K epoxide reductase C1 deficiency, gamma-carboxylase deficiency, bleeding associated with trauma, injury, and surgery, thrombosis, thrombocytopenia, stroke, coagulopathy, disseminated intravascular coagulation (DIC), Bernard Soulier syndrome, Glanzman thromblastemia, storage pool deficiency, and hemophilia; pharmaceutical preparations and substances for the treatment of viral diseases, metabolic diseases, endocrine diseases, musculoskeletal diseases, cardiovascular diseases, hematologic diseases, cardiopulmonary diseases, genitourinary diseases, sexual dysfunction, oncological diseases, hepatological diseases, ophthalmic diseases, respiratory diseases, neurological diseases, gastrointestinal diseases, hormonal diseases, dermatological diseases, coagulation disorders, diseases of the blood and blood-forming organs, psychiatric and immune system related diseases and disorders, congenital bleeding disorders and acquired bleeding disorders, disorders due to a deficiency of a coagulation factor, disorders due to the presence of acquired inhibitors to a coagulation factor, hematologic disorders, hemorrhagic disorders, Von Willebrands' disease, disorders resulting from anticoagulant therapy with a vitamin-K antagonist, hereditary platelet disorders, vitamin K epoxide reductase C1 deficiency, gamma-carboxylase deficiency, bleeding associated with trauma, injury, and surgery, thrombosis, thrombocytopenia, stroke, coagulopathy, disseminated intravascular coagulation (DIC), Bernard Soulier syndrome, Glanzman thromblastemia, storage pool deficiency, and hemophilia; diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat; pesticides; first aid kits; dental abrasives.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98339914

Mark Type

No Service/Collective Mark

Attorney Docket Number

No USTF10168845

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
11th Dec 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Sep 2024PUBLISHED FOR OPPOSITION
28th Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
30th Jul 2024ASSIGNED TO EXAMINER
18th Apr 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03rd Jan 2024NEW APPLICATION ENTERED